GENE ONLINE|News &
Opinion
Blog

Licensing
J&J Puts Up $245 Million for Two Promising Autologous CAR-T Candidates
2023-05-05
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
Merck Strikes $50 Million Deal with ModeX For Rights to EBV Vaccine
2023-03-08
Lineage Books Eterna For Allogeneic Cell Therapies In License Option Deal
2023-02-23
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Following Amgen, Hummingbird Jumps Onto Synaffix’s ADC Platform In $150 Million Licensing Deal
2023-01-06
PDS Buys IL-12 Targeting Therapy From Merck KGaA for $121 Million Biobucks
2023-01-04
Jounce Sells Anti-CCR8 Antibody to Gilead, Forgoing $645 Million In Milestones
2022-12-28
Jazz Opts Into License Zymeworks’ Solid Tumor Med With $325 Million Payment
2022-12-21
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
LG Chem Lands Innovent As China Partner For Gout Candidate
2022-12-15
1 2 3 7
LATEST
From Sweet to Risky: The Alarming Findings on Sucralose’s Genotoxicity
2023-06-07
GHG Emissions as a ESG Metric
2023-06-07
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
2023-06-07
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
2023-06-06
The Emergence of General AI for Medicine: Medical Applications of ChatGPT
2023-06-06
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
Scroll to Top